This study aims to assess the mental health impact and needs associated with COVID-19 in Spain
Description of the Study:
- Title: MIND/COVID-19: Mental Health Impact and NeeDs Associated With COVID-19: a Comprehensive National Evaluation in Spain.
- Principal investigator: Jordi Alonso.
- Co-investigators: Juan De Dios Molina Martin, Rafael M. Ortí-Lucas, Nieves López-Fresneña, Mara Parellada, M. Joao Forjaz, Eduard Vieta, Aurora Pérez Zapata, Maria Nieves Plana Farras, Josep Maria Har, Enric Aragonès, Alma D. Martínez De Salázar, José María Pelayo-Terán, Ana González-Pinto, Iratxe Urreta, Meritxell Espuga Consol Serra, Víctor Pérez-Solà José Ignacio Pijoan, Cristina Rius, Isabel Del Cura-González, Andrés Aragón-Peña, María Teresa Puig Ferran Sanz and Mireia Campos.
- Centers of Implementation: Hospital Universitario 12 de Octubre, Instituto de Salud Carlos III, Universitat Pompeu Fabra, Public Health Agency of Barcelona, Jordi Gol i Gurina Foundation, Sistema de Emergencias Médicas de Cataluña (SEM), Agència de Qualitat i Avaluació Sanitàries Gerencia de Atención Primaria de Madrid -FIIBAP, Hospital del Mar, Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, Fundació Clinic per a la Recerca Biomédica, Hospital Vall d’Hebron, Hospital Clínico Universitario de Valencia, Hospital General Universitario Gregorio Marañón, Hospital Universitario Príncipe de Asturias, Hospital El Bierzo, Hospital Universitario Araba, Hospital Universitario Donostia, Hospital de Cruces, Hospital Universitario Torrecárdenas and Parc Sanitari Sant Joan de Déu.
- Study Population:
– Health Care Workers (n>10.000)
– General Population of Spain (n=3.500)
– COVID-19 cases and close contacts (n>2.000)
- Study Type: Prospective cohort study.
Objectives of the Study:
(1) Assess the mental and psychological health impact of the COVID-19 pandemic in Spain, among healthcare workers, COVID-19 patients and close contacts in isolation or quarantine and the general adult population.
(2) Identify risk and protective factors for adverse mental health occurrence and persistence.
(3) Quantify the use of available mental health resources.
(4) Quantify and characterise unmet mental health needs.
(1) Assess the potential benefit of using available mental health resources.
(2) Provide a baseline for understanding the impact on mental and psychological health related to COVID-19 over time in Spain.
More about this Study:
Scientific Context: The MINDCOVID project aims to study the mental health of healthcare workers, as well as COVID-19 patients (and their close contacts) and a sample of the general adult Spanish population. All of them are vulnerable to the foreseeable psychological impact of the COVID-19 pandemic.
Added Value: MINDCOVID focuses its research on providing a comprehensive assessment of the impact of the current COVID-19 pandemic on the mental health of the Spanish population.
Other studies about Mental Health:
This study aims to demonstrate efficacy of Montelukast for patients with persistent COVID-19 to help them improve their quality of life.
CIBERES UCI COVID is a fundamental study that will improve care of critical patients infected by COVID-19.
A Russian study to determine the severity and lethality of COVID-19 infection in patients with hematologic diseases.
Determining whether there is protection against reinfection is important for controlling healthcare workers implications during the pandemic due to their continous professional contact with COVID-19 patients
Antimicrobial stewardship approaches urgently need to be reinforced during the COVID-19 pandemic. This study evaluates the impact of the COVID-19 on antibiotic consumption.
This retrospective observational study aims to clinically characterise patients with COVID-19 in Primary Care in Catalonia.
Chest Computed Tomography (CT) + Artificial Intelligence (AI): a potential complementary approach to RT-PCR for COVID-19 detection and lesion characterization.
An ultrasound severity index has been created to demonstrate the effectiveness of portable lung ultrasound both for diagnosis and for daily monitoring of patients with COVID-19 pneumonia.